Nature Cell Biology, Published online: 14 August 2026; doi:10.1038/s41556-026-02048-x Kim et al. demonstrate a non-canonical function for EZH2 in modulating cholesterol metabolism and tumour development by interacting with SREBP2, which may be targeted by PROTACs to disrupt its oncogenic activity.